Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future Directions

ανά Yardley, Denise A.
Έκδοση 2013

Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes

ανά Yardley, Denise A.
Έκδοση 2013

Taxanes in the elderly patient with metastatic breast cancer

ανά Yardley, Denise A
Τόπος έκδοσης Breast Cancer (Dove Med Press) (2015)

Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer

ανά Yardley, Denise A
Τόπος έκδοσης Breast Cancer (Dove Med Press) (2016)

Healthcare Resource Use and Expenditures among Metastatic Breast Cancer Patients Treated with HER2-Targeted Agents

ανά Meyer, Nicole, Hao, Yanni, Song, Xue, Shi, Nianwen, Johnson, William, Willemann Rogerio, Jaqueline, Yardley, Denise A.
Έκδοση 2014

Molecular Profiling in Unknown Primary Cancer: Accuracy of Tissue of Origin Prediction

ανά Greco, F. Anthony, Spigel, David R., Yardley, Denise A., Erlander, Mark G., Ma, Xiao-Jun, Hainsworth, John D.
Έκδοση 2010

First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial

ανά Liu, Minetta C, Janni, Wolfgang, Georgoulias, Vassilis, Yardley, Denise A, Harbeck, Nadia, Wei, Xin, McGovern, Desmond, Beck, Robert
Τόπος έκδοσης Cancer Manag Res (2019)

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer

ανά Yardley, Denise A., Kaufman, Peter A., Brufsky, Adam, Yood, Marianne Ulcickas, Rugo, Hope, Mayer, Musa, Quah, Cheng, Yoo, Bongin, Tripathy, Debu
Έκδοση 2014

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer

ανά Rugo, Hope S., Brufsky, Adam M., Yood, Marianne Ulcickas, Tripathy, Debu, Kaufman, Peter A., Mayer, Musa, Yoo, Bongin, Abidoye, Oyewale O., Yardley, Denise A.
Έκδοση 2013

Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study

ανά Kaufman, Peter A., Brufsky, Adam M., Mayer, Musa, Rugo, Hope S., Tripathy, Debu, Yood, Marianne Ulcickas, Feng, Shibao, Wang, Lisa I., Quah, Cheng S., Yardley, Denise A.
Έκδοση 2012

Phase II study evaluating lapatinib in combination with nab-paclitaxel in HER2-overexpressing metastatic breast cancer patients who have received no more than one prior chemotherap...

ανά Yardley, Denise A., Hart, Lowell, Bosserman, Linda, Salleh, Mansoor N., Waterhouse, David M., Hagan, Maura K., Richards, Paul, DeSilvio, Michelle L., Mahoney, Janine M., Nagarwala, Yasir
Έκδοση 2012

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve,...

ανά Miller, Kathy, Cortes, Javier, Hurvitz, Sara A., Krop, Ian E., Tripathy, Debu, Verma, Sunil, Riahi, Kaveh, Reynolds, Joseph G., Wickham, Thomas J., Molnar, Istvan, Yardley, Denise A.
Τόπος έκδοσης BMC Cancer (2016)

Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-...

ανά Yardley, Denise A., Ismail-Khan, Roohi R., Melichar, Bohuslav, Lichinitser, Mikhail, Munster, Pamela N., Klein, Pamela M., Cruickshank, Scott, Miller, Kathy D., Lee, Min J., Trepel, Jane B
Τόπος έκδοσης J Clin Oncol (2013)

MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, as a single agent, in patients with refractory HR+/HER2− metastatic breast cancer

ανά Dickler, Maura N., Tolaney, Sara M., Rugo, Hope S., Cortés, Javier, Diéras, Véronique, Patt, Debra, Wildiers, Hans, Hudis, Clifford A., O’Shaughnessy, Joyce, Zamora, Esther, Yardley, Denise A., Frenzel, Martin, Koustenis, Andrew, Baselga, José
Τόπος έκδοσης Clin Cancer Res (2017)

De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

ανά Tripathy, Debu, Brufsky, Adam, Cobleigh, Melody, Jahanzeb, Mohammad, Kaufman, Peter A., Mason, Ginny, O'Shaughnessy, Joyce, Rugo, Hope S., Swain, Sandra M., Yardley, Denise A., Chu, Laura, Li, Haocheng, Antao, Vincent, Hurvitz, Sara A.
Τόπος έκδοσης Oncologist (2019)

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer...

ανά Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Τόπος έκδοσης Trials (2015)

Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative b...

ανά Yardley, Denise A., Brufsky, Adam, Coleman, Robert E., Conte, Pierfranco F., Cortes, Javier, Glück, Stefan, Nabholtz, Jean-Mark A., O’Shaughnessy, Joyce, Beck, Robert M., Ko, Amy, Renschler, Markus F., Barton, Debora, Harbeck, Nadia
Τόπος έκδοσης Trials (2016)

Assessing the discordance rate between local and central HER2 testing in women with locally determined HER2-negative breast cancer

ανά Kaufman, Peter A, Bloom, Kenneth J, Burris, Howard, Gralow, Julie R, Mayer, Musa, Pegram, Mark, Rugo, Hope S, Swain, Sandra M, Yardley, Denise A, Chau, Miu, Lalla, Deepa, Yoo, Bongin, Brammer, Melissa G, Vogel, Charles L
Τόπος έκδοσης Cancer (2014)

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

ανά Gradishar, William J., Yardley, Denise A., Layman, Rachel, Sparano, Joseph A., Chuang, Ellen, Northfelt, Donald W., Schwartz, Gary N., Youssoufian, Hagop, Tang, Shande, Novosiadly, Ruslan, Forest, Amelie, Nguyen, Tuan S., Cosaert, Jan, Grebennik, Dmitri, Haluska, Paul
Τόπος έκδοσης Clin Cancer Res (2015)

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical Trial

ανά Jerusalem, Guy, de Boer, Richard H., Hurvitz, Sara, Yardley, Denise A., Kovalenko, Elena, Ejlertsen, Bent, Blau, Sibel, Özgüroğlu, Mustafa, Landherr, László, Ewertz, Marianne, Taran, Tetiana, Fan, Jenna, Noel-Baron, Florence, Louveau, Anne-Laure, Burris, Howard
Τόπος έκδοσης JAMA Oncol (2018)